Nutrition Health Chat: Tuesday, Dec. 8th, 5-6 PM Eastern. Learn how vitamins, minerals, and phytonutrients affect your health. Free live Q&A. Join us!
Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum.  ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
 | 

new treatment for Chronic hepatitis B

by deeps00, Dec 08, 2008 11:02PM
Tags: viread
Tenofovir a  nucleotide analogue can now be used for treating CHB,,, can anyone tell me abt the nephrotoxicity profile of the drug
Member Comments (3)

by naic, Dec 09, 2008 01:14AM
To: deeps00
do you mean that Tenofovir can make HBsAg positive to HBsAg negative? is that for real?

by zellyf, Dec 09, 2008 10:01AM
No, it reduces viral load.

I would try googling tenofovir with nephrotoxic.

by cajim, Dec 09, 2008 11:22AM
New Onset or Worsening Renal Impairment

Tenofovir is principally eliminated by the kidney. Renal impairment, including cases of acute renal failure and Fanconi syndrome (renal tubular injury with severe hypophosphatemia), has been reported with the use of VIREAD [See ADVERSE REACTIONS].

It is recommended that creatinine clearance be calculated in all patients prior to initiating therapy and as clinically appropriate during therapy with VIREAD. Routine monitoring of calculated creatinine clearance and serum phosphorus should be performed in patients at risk for renal impairment.

Dosing interval adjustment of VIREAD and close monitoring of renal function are recommended in all patients with creatinine clearance <50 mL/min [See DOSAGE AND ADMINISTRATION]. No safety or efficacy data are available in patients with renal impairment who received VIREAD using these dosing guidelines, so the potential benefit of VIREAD therapy should be assessed against the potential risk of renal toxicity.

VIREAD should be avoided with concurrent or recent use of a nephrotoxic agent.
Related discussions
Post Comment
To
Comment
Post Comment
Recent Activity
ceruleandreams commented on Big News Tomorrow
7 hrs ago
rudy1222 joined this community
Welcome them!
10 hrs ago
rooboo is here to help
rooboo commented on Big News Tomorrow
Dec 02
LIZZIE LOU commented on Big News Tomorrow
Dec 02
April63 commented on treatment
Dec 02
charmaine2 joined this community
Welcome them!
Dec 01
joe710 commented on Big News Tomorrow
Dec 01
RSS Expert Activity
When the Mexican Drug Trade Hits th...
12 hrs ago by Arnold L Goldman, D.V.M.
In the ER: Coffee, anyone?
Dec 02 by Jon Geller, D.V.M.
My animal blogs! 
Dec 02 by Justine Lee, D.V.M., DACVECC
Community Members